Elexacaftor (VX-445), a next-generation CFTR corrector that is part of the triple-combination therapy Trikafta, is…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Health Canada has granted priority review to Vertex Pharmaceuticals’ application seeking the approval of Kalydeco (ivacaftor) to treat cystic…
A non-invasive ultrasound imaging technique may be able to detect changes in the pancreas of children with cystic fibrosis…
AirPhysio, a handheld device designed to help clear the mucus that builds up in the lungs of people with…
A nonprofit’s entry in the Philadelphia Marathon, Team EE is looking for enthusiastic people to join it for the November…
Depression and anxiety are common among people with cystic fibrosis (CF), a systematic review reports. The study “Global…
This year’s Cystic Fibrosis Foundation (CFF) Impact Grants will support three new virtual programs that support the well-being of people of…
Wrinkling on the palm of the hands after a short immersion in water may serve as a fast, easy and…
Functional residual capacity (FRC), a measure of the volume of air left in the lungs at the end of a…
Cystic fibrosis (CF) patients with specific variants in the Tensin 1 gene may be at risk of low body mass index…